Bayer injects €35m in biologics project expansion
Bayer HealthCare is investing €35m ($47m) in a new centre for the biotechnological production of ‘innovative’ pharmaceuticals to be used in clinical trials.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs